Application no. and date | 16195776.6 (espacenet) (Federated) (European Patent Register), 20111213 | Patent/reg. no. and date | DK/EP 3202413, 20180801 | Publication date | 20170809 | Priority no. and date | | EP pub. no. and date |
EP 3202413 20170809 | Effective date | | Applicant/owner | ImmuPharma France SA, 5 rue du Rhône
68100 Mulhouse, FR, Centre National de la Recherche Scientifique (C.N.R.S.), 3 rue Michel Ange
75794 Paris, FR | Applicant ref. no. | V146638 | Inventor | BRIAND, Jean-Paul, 4, quai Rouger de l'Isle
67000 Strasbourg, FR, ZIMMER, Robert, 5, rue du Rhône
68100 Mulhouse, FR, Muller, Sylviane, 4, quai Rouger de de l'Isle
67000 Strasbourg, FR | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 38/04 (2006.01) , C07K 7/08 (2006.01) | Title | MODIFICEREDE PEPTIDER OG ANVENDELSE HERAF TIL BEHANDLING AF AUTOIMMUNE
SYGDOMME | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|